Editor's Page

By Jason Hsu, MD

Honoring our Mentors

Novel Tech: A Self-Contained Implantable Biofactory

Failing Sight

Building bridges and deconstructing TRDs

The Inner Game of Vitreoretinal Surgery

Musings on Vail Vitrectomy 2025

The Home OCT evolution: Promises and pitfalls

Little Steps

Waste not, want not

The TermEYEnator: AI and the future of retina

Dazed and confused

A heavy burden

The Solow paradox

FDA engagement

Breaking down silos

Synthetic considerations

The complement era dawns

Leave some work for tomorrow

What's in a number?

‘The FDA is on the line’

It's later than you think

OCT-ologists

Promises and pudding

2022: Banner year for clinical trials

Six and Counting

Making the pivot

Fluid is bad. Or is it?

Untapped insights

Asymptomatic patients

More balance

Year of uncertainty

The anxiety around us

Diversity and a vaccine

Quarantine

Caution ahead: Confronting DME

Too many meetings? Sign me up

Turning the tide on GA

Family of Five

Clinically relevant

In search of a better mousetrap

Weather forecasting

The devastation of diabetic retinopathy

The Dawn Of AI in Retina

Show Me the Vision

Power Athlete, Deep Sleeper

Advancing DR and DME Management

Deep Learning, MD

Flooding: Harvey, Irma and the Retina

Summer Reading

‘Genetics, The Future is Now’

The Good Fight

Retina Specialist’s Legion of Honor

Forever, for Now

HORV to Zika

Reptilian Trauma And ICD-10

Reptilian Trauma And ICD-10

Retinal Imaging Revolutions

Consequences Of Surviving the Black Death

Welcome and Hang On!